Discovery & Development:From Target ID to Clinical Trials
E2F
CSP
PUMA
Target
Identification
Target
Validation
Lead
Generation
Lead
Optimization
Pharmacology
Preclinical
Clinical
Regulatory
CO 501
pADME
eADME
Animal
Facility
Oncology and Inflammation
Portfolio;
Pharma Partnerships
Automated
Molecular
Assembly Plant
(AMAP)
Activated
Checkpoint
Therapy
(ACT)
IND
filed
Previous slide
Next slide
Back to first slide
View graphic version